Amphastar Pharmaceuticals Inc expected to post earnings of 77 cents a share - Earnings Preview

Amphastar Pharmaceuticals,

07/05/2024 03:12

* Amphastar Pharmaceuticals Inc  AMPH.OQ   AMPH.O  is
expected
to show a rise in quarterly revenue when it reports  results on
May 8 for the period ending March 31 2024
    * The Rancho Cucamonga California-based  company is expected
to
report a 24.8% increase in revenue to $174.713 million from
$140.02 million a year ago, according to the mean estimate from
6 analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Amphastar
Pharmaceuticals Inc
is for earnings of 77 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 1.8%
in the last three months. ​
    * Wall Street's median 12-month price target for Amphastar
Pharmaceuticals Inc is $66.00​, above​ its last closing price
of $42.68. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023  0.92        0.93       0.88      Missed  -4.9
 Sep. 30 2023  0.70        0.69       1.15      Beat    65.5
 Jun. 30 2023  0.56        0.56       0.65      Beat    16​
 Jan. 1 0001   0.47        0.48       0.62      Beat    30.4
 ​​Dec.        0.40        0.41       0.73      Beat    79.7
 31 2022                                                
 Sep. 30 2022  0.40        0.39       0.38      Missed  -3.6​
 Jun. 30 2022  0.35        0.35       0.39      Beat    12.1
 Mar. 31 2022  0.36        0.36       0.47      Beat    30.6
 This summary was machine generated May 7 at 02:12 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)